Gene Weaver is a naturally derived programmable tool for controlled cutting and precision insertion of large genetic payloads.
Gene Weaver has raised $515K in total funding. The most recent round was Grant. The last funding was announced in May 2025.
Gene Weaver's investors include Bill & Melinda Gates Foundation.
Gene Weaver is headquartered in Cambridge, United Kingdom.
Gene Weaver is a naturally derived programmable tool for controlled cutting and precision insertion of large genetic payloads.
Gene Weaver is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gene Weaver — Funding & Investors." VCBacked, May 7, 2025, https://www.vcbacked.co/company/gene-weaver. Accessed August 14, 2026.
VCBacked. (2025). Gene Weaver — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/gene-weaver
{{cite web |title=Gene Weaver — Funding & Investors |url=https://www.vcbacked.co/company/gene-weaver |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated